MDT IMPROVEMENT PROJECT. Professor Muntzer Mughal, UCLH
|
|
- Jessica Cole
- 5 years ago
- Views:
Transcription
1 MDT IMPROVEMENT PROJECT Professor Muntzer Mughal, UCLH
2 1995..assessment and management of rare cancers in multidisciplinary teams the care of all patients with cancer should be formally reviewed by a specialist team
3 More patients, more complex, more therapies
4 Activity (patient discussions) Cost in million s
5 Challenges for cancer MDTs Time - increasing case-load & complex case-mix Increasing treatment options Demands on time of MDT Lead & members Preparation and attendance of MDMs Annual review meetings Leadership IT support Video links Data 5
6 1995 assessment and management of rare cancers in multidisciplinary teams 2000 the care of all patients with cancer should be formally reviewed by a specialist team 2015 Streamlining & more effective working 2017
7 MDT discussions should focus more on difficult cases and processes should be put in place to enable swifter decisions on patients going through standard treatment pathways. Recommendation 38: NHS England should encourage providers to streamline MDT processes such that specialist time is focused on those cancer cases that don t follow wellestablished clinical pathways, with other patients being discussed more briefly.
8 Identify protocolised treatment pathways. pre-mdt triage meeting to apply protocolised pathways. Minimum attendance based on quoracy. NHS England to run pilots to determine optimal attendance requirements. Develop referral proforma template to include minimum dataset including HNA, patient preferences, suitability for trials Real-time documentation of outcomes. Ensure regular morbidity & mortality meetings and quarterly operational meetings time in job plans 8
9 UCLH Cancer Collaborative MDT Improvement project MDT Improvement workshop July 2016 MDT visits (5 local, 8 specialist) Nov 2016 to March 2017 Questionnaires to MDT leads and co-ordinators Develop JD for MDT lead & co-ordinator Report published April 2017
10 Differences in MDTs Content Number of cases in the time available Information about the patient & preferences Stratification of cases Combination of benign & malignant Infrastructure Room, seating, screens, video-conferencing Process preparation and who does what Presentation of cases Recording of outcomes Consideration of cases for trials Chairing Involving team members Summarising discussion & outcomes Evidence of operational/review meetings 10
11 Length of meeting and number of cases Dur (mins)
12 21 Recommendations Leadership, infrastructure and attendance MDT lead & MDT co-ordinator JDs Quoracy Process Information about patient performance status & wishes Protocolised pathways Clear outcomes Governance & Improvement Morbidity & mortality SACT data Operational meetings Support Mentorship, support & development 12
13 Do MDT chairs have the time to prepare & lead? Does your job plan allow time for MDT preparation? 80% 70% 60% 50% 40% 30% 20% 10% 0% No Partly Yes Preperation is minimal due to the use of proformas Do you feel your role as MDT lead would benefit from a structured job description and recruitment process? 80% 70% 60% 50% 40% 30% 20% 10% 0% Yes no It would have been useful when I started JD would be beneficial but recruitment process would not We already have one (PAH) 13
14 120% % cases submitted with complete dataset 100% 80% 60% 40% 20% 0% Jul-16 Aug-16 Sep-16 Oct-16 Nov-16 Dec-16 Jan-17 Feb-17 RLH BHRUT WXH HUH PAH Other/Private Total 15
15 Protocolised management
16 Tumour Site Percentage in favour What percentage of patients do you feel could be resolved outside of the meeting - for example, through clearly defined treatment protocols and review by a smaller group? Overall 74% 31.00% Skin 89% 37.80% Urology 87% 35.30% Other (please specify) 81% 28.50% Children and Young People 79% 31.40% Lung 78% 26.90% Gynaecology 78% 28.20% Upper GI 75% 30.70% Breast 75% 33.70% Haematology 75% 32.90% Brain 74% 26.70% Sarcoma 73% 21.10% Palliative Care 67% 42.90% Colorectal 63% 27.90% Head and Neck 50% 25.00% CUP 43% 12.20%
17 Analysis of single OG Cancer smdt meeting Clinical details Question for MDT MDT outcome Suitable for pre- MDT triage Next step after pre-mdt Metastatic gastric adenoca, CT scan Treatment options Palliative care Yes Palliative care Adenoca oesoph, neoadjuvant chemo Review CT Liver lesion - for MRI? Adenoca stomach, CT - T3N1, staging lap Results of staging lap Cytology - positive, for palliative chemo Yes Refer to oncology OPC Perforated adenoca oesoph, CT & PET Case review For neoadjuvant chemo-rad No Metastatic SCC oesoph treated with chemorad CT to determine disease progression Disease progression Yes Oncology review SCC oesoph treated with chemorad, OGD? Recurrence Review histology Recurrent disease, discuss salvage surgery No Perforated adenoca oesoph, SCLN biopsy Review histology Benign, consider oesophagectomy No Metastatic SCC oesoph treated with chemorad, interval CT CT to determine disease progression Stable disease Yes Oncology review SCC oesoph treated with chemorad, surveillance PET CTExclude recurrence No recurrence Yes Continue surveillance SCC oesoph, CT - T3N2M0 Next step PET scan Yes PET scan Referral from sarcoma MDT - oesophageal nodules biopsied Histology Repeat OGD with mapping biopsies No Adenoca oesoph, CT- T3N1M0, PET - staging lap clear Next step Neoadjuvant chemo Yes Refer to oncology OPC Adenoca oesoph, CT - R adrenal mass & suspicious liver lesions Review CT Metastatic disease, palliative chemo Yes Refer to oncology OPC Adenoca oesoph, CT/PET - T3N2M0, co-morbidities Case discussion Review in surgical clinic to discuss optiona No Resected gastric cancer Review histology For adjuvant chemotherapy No High grade dysphasia on surveillance OGD for Barretts Review histology Repeat biopsy but patient not keen for further invx Adenoca stomach, CT - T3N1M1, bleeding Review case & imaging For palliative DXT No Adenoca oesoph, CT - T3N2M0 Review CT For PET scan Yes PET scan Adenoca oesoph, CT - T2N1M0 Review CT For PET scan Yes PET scan Adenoca stomach, CT - TxN1M1 Review CT Metastatic disease, palliative chemo Yes Refer to oncology OPC No Elderly patient with gastric outlet obstruction from gastric ca Review CT T3N2M1 disease - stenting? Elderly patient with early adeno oesoph, EMR Review histology Complete resection, for surveillance OGD No Resected gastric cancer Review histology ypt3n2r1, for adjuvant chemo No 18
18 Cases suitable for protocolised pathway Clinical details Question for MDT MDT outcome Suitable for pre-mdt triage Next step after pre-mdt Metastatic gastric adenoca, CT scan Treatment options Palliative care Yes Palliative care Adenoca stomach, CT - T3N1, staging lap Results of staging lap Cytology - positive, for palliative chemo Yes Refer to oncology OPC Metastatic SCC oesoph treated with chemorad CT to determine disease progression Disease progression Yes Oncology review Metastatic SCC oesoph treated with chemorad, interval CT CT to determine disease progression Stable disease Yes Oncology review SCC oesoph treated with chemorad, surveillance PET CT Exclude recurrence No recurrence Yes Continue surveillance SCC oesoph, CT - T3N2M0 Next step PET scan Yes PET scan Adenoca oesoph, CT- T3N1M0, PET - staging lap clear Next step Neoadjuvant chemo Yes Refer to oncology OPC Adenoca oesoph, CT - R adrenal mass & suspicious liver lesions Review CT Metastatic disease, palliative chemo Yes Refer to oncology OPC Adenoca oesoph, CT - T3N2M0 Review CT For PET scan Yes PET scan Adenoca oesoph, CT - T2N1M0 Review CT For PET scan Yes PET scan Adenoca stomach, CT - TxN1M1 Review CT Metastatic disease, palliative chemo Yes Refer to oncology OPC 19
19 Pre-MDT meeting 7 patients for oncology review 1 patient for palliative care 3 patients for PET scan 12 cases for discussion 7 patients for oncology review 1 patient for palliative care 3 patients for PET scan AT LEAST 2 DAYS IN TIMED PATHWAY FEWER CASES FOR DISCUSSION 20
20 Introducing protocolised management Develop pathways with MDTs & Pathway Boards Each MDT to determine who will triage? E.g. MDT lead, MDT co-ordinator, radiologist Ensure direct to next step patients listed on MDT agenda Systematic study & audit
21 Implementation of recommendations JD & time for MDT leads & co-ordinators Make patient information mandatory Consider setting up MDT leads forum Develop & pilot protocolised management pathways Develop datasets to report patient outcomes regularly to the MDT QI programme to support MDTs 22
Epidemiology, aetiology and the patient pathway in oesophageal and pancreatic cancers
Epidemiology, aetiology and the patient pathway in oesophageal and pancreatic cancers Dr Ian Chau Consultant Medical Oncologist Women's cancers Breast cancer introduction 3 What profession are you in?
More informationCT PET SCANNING for GIT Malignancies A clinician s perspective
CT PET SCANNING for GIT Malignancies A clinician s perspective Damon Bizos Head, Surgical Gastroenterology Charlotte Maxeke Johannesburg Academic Hospital Case presentation 54 year old with recent onset
More informationCancer Outcomes and Services Dataset. What is COSD? Skin Cancers Workshop October 2012
Cancer Outcomes and Services Dataset What is COSD? Skin Cancers Workshop October 2012 17 years ago......cancer registration and careful monitoring of treatment and outcomes are essential... Calman-Hine
More informationOesophago gastric cancer the disease and the challenges. Muntzer Mughal
Oesophago gastric cancer the disease and the challenges Muntzer Mughal Oesophago gastric cancer How common is it? What causes it? What are the symptoms? How is it treated? Recent advances in: Detection
More informationManchester Cancer Colorectal Pathway Board: Guidelines for management of colorectal hepatic metastases
Manchester Cancer Colorectal Pathway Board: Guidelines for management of colorectal hepatic metastases Date: April 2015 Date for review: April 2018 1. Principles The recognised specialist HPB MDT for Greater
More informationHaemato-oncology Clinical Forum. 20 th June 2013
Haemato-oncology Clinical Forum 20 th June 2013 Welcome Dr Majid Kazmi, LCA Haemato-oncology Pathway Group Chair Purpose of today Provide an update on progress of the LCA to date Identify priorities for
More informationCancer of Unknown Primary (CUP) Protocol
1 Department of Oncology. Cancer of Unknown Primary (CUP) Protocol Version: Document type: Document sponsor Designation Document author [ s] Designation[s] Approving committee / Group Ratified by: Date
More informationCancer Outcomes and Services Dataset: Implications for clinical teams
Cancer Outcomes and Services Dataset: Implications for clinical teams Mick Peake Clinical Lead, NCIN National Clinical Lead, NHS Cancer Improvement Consultant & Senior Lecturer in Respiratory Medicine,
More informationThe Single Cancer Pathway
The Single Cancer Pathway Background and Case for Change Case for Change (1) Broadly patient experience of cancer services in Wales is good: 93% of patients rate their care as 7/10 or better (WPES) But
More informationGuidelines for the Management of Prostate Cancer West Midlands Expert Advisory Group for Urological Cancer
Guidelines for the Management of Prostate Cancer West Midlands Expert Advisory Group for Urological Cancer West Midlands Clinical Networks and Clinical Senate Coversheet for Network Expert Advisory Group
More informationUpper GI Malignancies Imaging Guidelines for the Management of Gastric, Oesophageal & Pancreatic Cancers 2012
Upper GI Malignancies Imaging Guidelines for the Management of Gastric, Oesophageal & Pancreatic Cancers 2012 Version Control This is a controlled document please destroy all previous versions on receipt
More informationImproving services for upper GI (OG) cancer Application template (Version 2)
Trust Clinical lead Improving services for upper GI (OG) cancer Application template (Version 2) Managerial lead Date completed 14 June 2013 Barnet & Chase Farm Hospitals NHS Trust Dr Marta Carpani Upper
More informationStaging Issues: Lung Cancer & Mesothelioma. Mick Peake Clinical Lead, NCIN Chair, Lung SSCRG
Staging Issues: Lung Cancer & Mesothelioma Mick Peake Clinical Lead, NCIN Chair, Lung SSCRG Staging systems Non-Small Cell Lung Cancer (>85%): UICC TNM v6 used until 1.1.10 transition since then to v7
More informationNational Cancer Peer Review Sarcoma. Julia Hill Acting Deputy National Co-ordinator
National Cancer Peer Review Sarcoma Julia Hill Acting Deputy National Co-ordinator Improving Outcomes Guidance The Intentions of Improving Outcomes for People with Sarcoma Changes in the provision of care
More informationLCA Lung Clinical Forum. 21 st October 2014
LCA Lung Clinical Forum 21 st October 2014 Welcome Dr Liz Sawicka Chair - LCA Lung Pathway Group Succession planning Dr Kate Haire Consultant in Public Health Medicine, LCA Commissioning Intentions for
More informationService specification for Oesophago-gastric (OG) cancer
London Cancer: Service specification for Oesophago-gastric (OG) cancer April 2013 Version 2.1 OG Service Specification V2.1.docx 1. Introduction 1.1. London Cancer The cancer care providers of North East
More informationCOSD & Source of Referral
COSD & Source of Referral A Brief guide October 2014 Michael Sharpe Data Improvement Manager National Cancer Registration Service What is COSD? Cancer and Outcomes Services Dataset Clinical dataset for
More informationNational Oesophago-Gastric Cancer Audit New Patient Registration sheet Patients with Oesophageal High Grade Glandular Dysplasia
National Oesophago-Gastric Cancer Audit New Patient Registration sheet Patients with Oesophageal High Grade Glandular Dysplasia Patient Details Surname: NHS number: Forename: Postcode: Sex: Male Female
More informationOESOPHAGO-GASTRIC CANCER 2016
SOUTH EAST SCOTLAND CANCER NETWORK PROSPECTIVE CANCER AUDIT OESOPHAGO-GASTRIC CANCER 2016 COMPARATIVE AUDIT REPORT Mr Peter Lamb SCAN Lead Upper GI Cancer Clinician Dr Jonathan Fletcher, Consultant Physician,
More informationNorth of Scotland Cancer Network Clinical Management Guideline for Metastatic Malignancy of Undefined Primary Origin (MUO)
North of Scotland Cancer Network Clinical Management Guideline for Metastatic Malignancy of Undefined Primary Origin (MUO) UNCONTROLLED WHEN PRINTED DOCUMENT CONTROL Original Prepared by NMcL April 2016
More informationCancer of Unknown Primary Service
Cancer of Unknown Primary Service Dr Maurice Fernando Consultant In Specialist Palliative Care and CUP lead Doncaster and Bassetlaw Hospitals NHS FT Wakefield meeting -14-07-2016 CUP service CUP MDT
More informationUpper GI Cancer Quality Performance Indicators
Publication Report Upper GI Cancer Quality Performance Indicators Patients diagnosed during January 2013 to December 2015 Publication date 28 th March 2017 An Official Statistics Publication for Scotland
More informationCancer of Unknown Primary (CUP)
Cancer of Unknown Primary (CUP) Pathways and Guidelines V1.0 London Cancer September 2013 The following pathways and guidelines document has been compiled by the London Cancer CUP technical subgroup and
More informationHealth Board/Region: All-Wales
Peer Review: Cancer Sub-site: Gynaecology Health Board/Region: All-Wales Cycle: Second Date of review: February 2018 This report describes the findings and themes observed by clinical review panels during
More informationNICE guideline Published: 24 January 2018 nice.org.uk/guidance/ng83
Oesophago-gastric cancer: assessment and management in adults NICE guideline Published: 24 January 18 nice.org.uk/guidance/ng83 NICE 18. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationOne Palliative Care Annual Report
One 203 Palliative Care Annual Report One In 202, ASCO released a provisional clinical opinion stating that concurrent palliative care should be considered early in the course of advanced or metastatic
More informationNorthern Oesophago-Gastric Cancer Unit MDT meeting NECN Audit day 2012
Northern Oesophago-Gastric Cancer Unit MDT meeting NECN Audit day 2012 Helen Jaretzke, Angie Tate, Jon Shenfine, Paula Brookes, Leigh-Anne Phillips, Gillian Robinson, Jonathan Stoddart Methods Patients
More informationBladder Cancer Guidelines
Bladder Cancer Guidelines Agreed by Urology CSG: October 2011 Review Date: September 2013 Bladder Cancer 1. Referral Guidelines The following patients should be considered as potentially having bladder
More informationOvarian Cancer Quality Performance Indicators
Ovarian Cancer Quality Performance Indicators Patients diagnosed between October 2013 and September 2016 Publication date 20 February 2018 An Official Statistics publication for Scotland This is an Official
More informationNational Oesophago-Gastric Cancer Audit Progress Report 2014
National Oesophago-Gastric Cancer Audit Progress Report 2014 An Audit of the care received by people with Oesophago-Gastric Cancer in England and Wales 1 This report was prepared by Clinical Effectiveness
More informationFaster Cancer Treatment: Using a health target as the platform for delivering sustainable system changes
Faster Cancer Treatment: Using a health target as the platform for delivering sustainable system changes Organisation Name: Ko Awatea, Counties Manukau Health Presenter: Bob Diepeveen HRT 1520 Innovations
More informationUnknown Primary Service for patients at Chesterfield Royal Hospital
Unknown Primary Service for patients at Chesterfield Royal Hospital David Brooks Macmillan Consultant in Palliative Medicine Louise Merriman GP Cancer Lead With thanks to Macmillan Cancer Support, who
More informationLung Cancer MCN Work Plan 2017/18
Lung Cancer MCN Work Plan /18 Objective Deliverables / Outcomes Lead 1. Manage the development/review of Lung Cancer Management Guidelines Regional Management Guidelines circulated for implementation.
More informationTable 1 Standards and items to set up a PCU: general requirements and critical mass
Table 1 Standards and items to set up a PCU: general requirements and critical mass General requirements and European Prostate Cancer Units are structures managing sufficient volumes of patients with on-site
More informationDr Hilary Williams. Consultant in Medical Oncology at Velindre Cancer Centre
Dr Hilary Williams. Consultant in Medical Oncology at Velindre Cancer Centre Hilary.williams4@wales.nhs.uk Thinking about Acute Oncology. Why do we need acute oncology locally? What the Hub VCC provides
More informationGuidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer
Guidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer West Midlands Clinical Networks and Clinical Senate Coversheet for Network Expert Advisory Group
More informationHead and Neck Cancer 2010 COMPARATIVE AUDIT REPORT
SOUTH EAST SCOTLAND CANCER NETWORK PROSPECTIVE CANCER AUDIT Head and Neck Cancer 2010 COMPARATIVE AUDIT REPORT Mr Guy Vernham, NHS Lothian SCAN Lead Clinician Head & Neck Cancer Mr B Joshi, NHS Dumfries
More informationNational Breast Cancer Audit next steps. Martin Lee
National Breast Cancer Audit next steps Martin Lee National Cancer Audits Current Bowel Cancer Head & Neck Cancer Lung cancer Oesophagogastric cancer New Prostate Cancer - undergoing procurement Breast
More informationProstate cancer timed clinical pathways
Prostate cancer timed clinical pathways December 2017 1 Context This document sets out preliminary best practice timed clinical pathways for prostate cancer. It is anticipated that Cancer Alliances will
More informationHead and Neck Cancer MCN Work Plan 2017/18
Head and Neck Cancer MCN Work Plan /18 Objective Deliverables / Outcomes Lead 1. Manage the development/review of Head and Neck Cancer Management Guidelines and Clinical Guidance Documents. 1.1 Identify
More informationCOLORECTAL CARCINOMA
QUICK REFERENCE FOR HEALTHCARE PROVIDERS MANAGEMENT OF COLORECTAL CARCINOMA Ministry of Health Malaysia Malaysian Society of Colorectal Surgeons Malaysian Society of Gastroenterology & Hepatology Malaysian
More informationSE SCOTLAND CANCER NETWORK PROSPECTIVE CANCER AUDIT LUNG CANCER REPORT ON PATIENTS DIAGNOSED 1 JANUARY 31 DECEMBER 2009
SE SCOTLAND CANCER NETWORK PROSPECTIVE CANCER AUDIT LUNG CANCER REPORT ON PATIENTS DIAGNOSED 1 JANUARY 31 DECEMBER 2009 Dr Ron Fergusson SCAN Lead Lung Cancer Clinician Dr Colin Selby Dr Jakki Faccenda
More informationWhen to Refer for OGD and the Work Up of Upper GI Malignancies
When to Refer for OGD and the Work Up of Upper GI Malignancies Dr Hong Qiantai Registrar, Department of Surgery GP Forum 27 May 2017 38 year old female, non-smoker, BMI 29 Works as investment banker Presents
More informationCommissioning Upper GI Services in New NHS
Commissioning Upper GI Services in New NHS Oct 2013 Commissioning Upper GI Services NHS England s Role Role of the new Clinical Reference Groups Current Issues / Work Programme for Oesophago Gastric Clinical
More informationFaster Cancer Treatment Indicators: Use cases
Faster Cancer Treatment Indicators: Use cases 2014 Date: October 2014 Version: Owner: Status: v01 Ministry of Health Cancer Services Final Citation: Ministry of Health. 2014. Faster Cancer Treatment Indicators:
More informationGuidelines for the Management of Bladder Cancer West Midlands Expert Advisory Group for Urological Cancer
Guidelines for the Management of Bladder Cancer West Midlands Expert Advisory Group for Urological Cancer West Midlands Clinical Networks and Clinical Senate Coversheet for Network Expert Advisory Group
More informationUsing Cancer Registration and MDT Data to Provide Information on Recurrent and Metastatic Breast Cancer
Using Cancer Registration and MDT Data to Provide Information on Recurrent and Metastatic Breast Cancer Dr Gill Lawrence, WM KIT, on behalf of Breast SSCRG Cancer Outcomes Conference, Brighton, June 2013
More informationHow a fully integrated Acute Oncology Service can benefit the busy medical unit
How a fully integrated Acute Oncology Service can benefit the busy medical unit Dr. Pauline Leonard MD FRCP Consultant Medical Oncologist Whittington Health Over the next 35 mins Briefly remind you of
More informationADJUVANT CHEMOTHERAPY...
Colorectal Pathway Board: Non-Surgical Oncology Guidelines October 2015 Organization» Table of Contents ADJUVANT CHEMOTHERAPY... 2 DUKES C/ TNM STAGE 3... 2 DUKES B/ TNM STAGE 2... 3 LOCALLY ADVANCED
More informationANNUAL CLINICAL REPORT 2016: GYNAECOLOGICAL ONCOLOGY COLPOSCOPY. Lois Eva Clinical Director
ANNUAL CLINICAL REPORT 2016: GYNAECOLOGICAL ONCOLOGY COLPOSCOPY Lois Eva Clinical Director Colposcopy 2016 2067 Colposcopies, 65% initial assessments 40% of referrals are for women
More informationNational Cancer Peer Review Programme
National Cancer Peer Review Programme Julia Hill Acting Deputy National Co-ordinator What is Cancer Peer Review? A quality assurance process for cancer services. An integral part of Improving Outcomes
More informationGuideline for the Management of Vulval Cancer
Version History Guideline for the Management of Vulval Cancer Version Date Brief Summary of Change Issued 2.0 20.02.08 Endorsed by the Governance Committee 2.1 19.11.10 Circulated at NSSG meeting 2.2 13.04.11
More information3.1 Investigations for Patients Presenting with Haematuria Table 1
3.1 Investigations for Patients Presenting with Haematuria Table 1 Patients at risk of bacterial endocarditis should be given antibiotic prophylaxis as per local guidelines. Patients with heart valve replacements
More informationVacancy list Pathway Boards
Vacancy list Pathway Boards The table below includes all the current vacancies for Pathway Boards. If you would like to apply to be a patient and carer representative on a Pathway Board, you need to have
More informationCommissioning Chemotherapy Services Conference. Issues of consent in systemic therapy
Commissioning Chemotherapy Services Conference Issues of consent in systemic therapy Dr Janine Mansi Consultant Medical Oncologist 28 th November 2017 Introduction Background and context What we have done
More informationBrighton and Sussex University Hospitals NHS Trust Board of Directors. Mark Smith Chief Operating Officer
Meeting: Brighton and Sussex University Hospitals NHS Trust Board of Directors Date: 24 th August 2015 Board Sponsor: Paper Author: Subject: Mark Smith Chief Operating Officer Clinical Director and Directorate
More informationDEPARTMENT OF ONCOLOGY ELECTIVE
DEPARTMENT OF ONCOLOGY ELECTIVE 2015-2016 www.uwo.ca/oncology Oncology Elective Program Administrator: Ms. Kimberly Trudgeon Room A4-901C (Admin) LHSC London Regional Cancer Centre (Victoria Campus) Phone:
More informationUpper GI Cancer Network Site-Specific Group. Work Programme/Service Delivery Plan 2011/14
Upper GI Cancer Network Site-Specific Group Work Programme/Service Delivery Plan 2011/14 1 UPPER GI NSSG Work Programme/Service Delivery Plan AGREEMENT COVER SHEET 2011/14 This Work Programme has been
More informationIndex. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.
Surg Oncol Clin N Am 16 (2007) 465 469 Index Note: Page numbers of article titles are in boldface type. A Adjuvant therapy, preoperative for gastric cancer, staging and, 339 B Breast cancer, metabolic
More informationNorthern Suburbs Clinic for Lung Cancer (NSCLC): Targeting Lung Cancer
Northern Suburbs Clinic for Lung Cancer (NSCLC): Targeting Lung Cancer Page 1 Phuong Tran (Rad Onc) Lung Cancer Most common cause of cancer related deaths in Australia 19% of all cancer deaths Survival
More informationTrust Board of Directors Public. Denise Gale. For Assurance and Information NOT APPLICABLE NOT APPLICABLE NOT APPLICABLE NOT APPLICABLE
NLG(18)014 DATE OF MEETING 30 January 2018 REPORT FOR Trust Board of Directors Public REPORT FROM Richard Sunley, Deputy Chief Executive CONTACT OFFICER Denise Gale SUBJECT Cancer Performance and Backlog
More informationNational Optimal Lung Cancer Pathway
National Optimal Lung Cancer Pathway This document was produced by the Lung Clinical Expert Group 2017 Document Title: National Optimal Lung Cancer Pathway and Implementation Guide Date of issue: August
More informationPATHWAY FOR INVESTIGATION OF ADULTS PRESENTING WITH ASCITES. U/S Abdo/pelvis shows ascites without obvious evidence of 1 liver disease
PATHWAY FOR INVESTIGATION OF ADULTS PRESENTING WITH ASCITES U/S Abdo/pelvis shows ascites without obvious evidence of 1 liver disease Refer back to original requester with this paperwork and review previous
More informationImproving Outcomes for People with Sarcoma
NHS National Institute for Health and Clinical Excellence Guidance on Cancer Services Improving Outcomes for People with Sarcoma List of All Recommendations March 2006 Developed for NICE by the National
More informationThe Role of an Upper GI Clinical Nurse Specialist
The Role of an Upper GI Clinical Nurse Specialist At a District General Hospital At Chesterfield Royal Hospital Emma Waterfield & Jessica Rouse Emma Waterfield I have worked at Chesterfield Royal Hospital
More informationThe ACE Programme. Multidisciplinary Diagnostic Centres (Wave 2) Cancer Cascade Reading, 22nd November 2018
The ACE Programme Multidisciplinary Diagnostic Centres (Wave 2) Cancer Cascade Reading, 22nd November 2018 Veronique Poirier ACE Programme Data Manager Title ACE Programme overview An early diagnosis initiative
More informationPalliative care - the opportunities. Dr David Brooks Macmillan Consultant in Palliative Medicine Chesterfield Royal Hospital
Palliative care - the opportunities Dr David Brooks Macmillan Consultant in Palliative Medicine Chesterfield Royal Hospital Our Commitment to you for end of life care The Government Response to the
More informationDiagnosing Pancreatic Cancer Challenges and Developments
Diagnosing Pancreatic Cancer Challenges and Developments PCUK 15 TH October 2018 Dr Andrew Millar MDC Clinical Lead UCLH Cancer Alliance Gastroenterologist and Hepatologist North Middlesex University Hospital
More informationGreater Manchester Cancer Services
HPB PATHWAY BOARD MEETING MINUTES DATE: 14/04/2014 Greater Manchester Cancer Services part of Manchester Cancer In Attendance: Mr. Derek O Neill Ms. Caroline McCall Prof. Juan Valle Dr. Konrad Koss Ms.
More informationActivity Report July 2012 June 2013
Urological Cancers Managed Clinical Network Activity Report July 2012 June 2013 Mr Seamus Teahan Consultant Urologist MCN Clinical Lead Tom Kane MCN Manager 1 CONTENTS EXECUTIVE SUMMARY 3 1. INTRODUCTION
More informationScottish Cancer Taskforce: National Cancer Quality Steering Group Cancer Clinical Audit
Scottish Cancer Taskforce: National Cancer Quality Steering Group Cancer Clinical Audit National Cancer Clinical Audit: Baseline Survey Report (May 09) Purpose: The purpose of this paper is to provide
More informationEnterprise Interest None
Enterprise Interest None Cervical Cancer -Management of late stages ESP meeting Bilbao Spain 2018 Dr Mary McCormack PhD FRCR Consultant Clinical Oncologist University College Hospital London On behalf
More informationAcute Oncology: Service Provision in Smaller Cancer Centres Ernie Marshall Clatterbridge Centre for Oncology
Acute Oncology: Service Provision in Smaller Cancer Centres Ernie Marshall Clatterbridge Centre for Oncology Whiston Hospital St Helen s Hospital 350,000 population ~1000 beds Regional Plastics Unit DGH
More informationSt. Joseph s Regional Thoracic Program. Dr. Yaron Shargall (Head, Thoracic Surgery) St. Joseph s Healthcare Hamilton
St. Joseph s Regional Thoracic Program Dr. Yaron Shargall (Head, Thoracic Surgery) St. Joseph s Healthcare Hamilton SJHH REGIONAL THORACIC PROGRAM Collaboration & Integration Thoracic Surgery - Malignant
More informationSELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM)
SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MDT Lead Clinician GMCN ROYAL WOLVERHAMPTON HOSPITALS The Royal Wolverhampton Hospitals Trust Lung MDT (11-2C-1) - 2011/12 Dr Angela Morgan
More informationDefinition of focal areas
Organ-specific requirements for diagnosis and treatment in oncology centres The underlying aim is to discuss the various tumour entities in a joint, interdisciplinary, weekly conference. The tumour conference
More informationShared Care Pathway for Soft Tissue Sarcomas Presenting to Site Specialised MDTs. Gynaecological sarcomas Version 1
Shared Care Pathway for Soft Tissue Sarcomas Presenting to Site Specialised MDTs Gynaecological sarcomas Version 1 Background This guidance is to provide direction for the management of patients with sarcomas
More informationANNEX 1 OBJECTIVES. At the completion of the training period, the fellow should be able to:
1 ANNEX 1 OBJECTIVES At the completion of the training period, the fellow should be able to: 1. Breast Surgery Evaluate and manage common benign and malignant breast conditions. Assess the indications
More informationHow can we facilitate cross-boundary working in Greater Manchester?
How can we facilitate cross-boundary working in Greater Manchester? Emma Halkyard Nurse Clinician Cross boundary working: where are we now? Our patients are complex Our pathways are complex Our treatments
More informationCo-morbidity: a summary of issues from the NCIN Site-Specific Clinical Reference Groups Dr Mick Peake
Co-morbidity: a summary of issues from the NCIN Site-Specific Clinical Reference Groups Dr Mick Peake Clinical Lead, NCIN National Clinical Lead, NHS Cancer Improvement Questionnaire to Site- Specific
More informationActivity Report April 2012 March 2013
North, South East and West of Scotland Cancer Networks HepatoPancreatoBiliary Cancers National Managed Clinical Network Activity Report April 2012 March 2013 Mr Colin McKay Consultant Surgeon NMCN Clinical
More informationNCIN Conference Feedback 2015
NCIN Conference Feedback 2015 Parallel Sessions Treatments (Black type is the topic; blue type are comments) The use of population and research data in the development of guidelines for cancer treatment
More informationNational Optimal Lung Cancer Pathways. Dr Sadia Anwar Nottingham University Hospitals NHS Trust Clinical Lead for Lung Cancer
National Optimal Lung Cancer Pathways Dr Sadia Anwar ttingham University Hospitals NHS Trust Clinical Lead for Lung Cancer Overview How NOLCP evolved How it relates to national guidance Pathways Implementation
More informationAudit Report. Upper GI Cancer Quality Performance Indicators. Report of the 2016 Clinical Audit Data. West of Scotland Cancer Network
Upper Gastro-intestinal Cancer Managed Clinical Network Audit Report Upper GI Cancer Quality Performance Indicators Report of the 216 Clinical Audit Data Mr Matthew Forshaw MCN Clinical Lead Tracey Cole
More informationActivity Report April 2013 March 2014
North, South East and West of Scotland Cancer Networks HepatoPancreatoBiliary Cancers National Managed Clinical Network Activity Report April 2013 March 2014 Mr Colin McKay Consultant Surgeon NMCN Clinical
More informationCancer Improvement Plan Update. September 2014
Cancer Improvement Plan Update September 2014 1 Contents Page 1. Introduction 3 2. Key Achievements 4-5 3. Update on Independent Review Recommendations 6-13 4. Update on IST Recommendations 14-15 5. Update
More informationLung cancer timed clinical pathways
Lung cancer timed clinical pathways December 2017 1 Context This document sets out best practice timed clinical pathways for lung cancer. It is anticipated that all Cancer Alliances will audit against
More informationInformatics in the new NHS : PHE and NCIN 9 months on. Nicky Coombes National Cancer Intelligence Network
Informatics in the new NHS : PHE and NCIN 9 months on. Nicky Coombes National Cancer Intelligence Network What was then... Key Funding Accountability Regulation Advice Parliament NICE Department of Health
More informationCommissioning Urology Services in New NHS
Commissioning Urology Services in New NHS Oct 2013 Commissioning Urology Services NHS England s Role Role of the new Clinical Reference Groups Current Issues / Work Programme for Urology Clinical Reference
More informationLean Approaches for System Transformation in Endoscopy
Lean Approaches for System Transformation in Endoscopy 2016 National Health Leadership Conference June 7, 2016 Jane Curtis Jonathon Drabik Denis Fortier Dawn Ridd Eileen Vodden Starting a Movement Lean
More informationACOS Inquiry and Response Selected Inquires CS Tumor Size/Extension Evaluation, CS Lymph Nodes Evaluation, CS Metastasis at Diagnosis Evaluation *
ACOS Inquiry and Response Selected Inquires CS Tumor Size/Extension Evaluation, CS Lymph Nodes Evaluation, CS Metastasis at Diagnosis Evaluation * CS Tumor Size/Extension Evaluation 24842 12/11/2007: Q:
More informationGuidelines for the Management of Bladder Cancer
Guidelines for the Management of Bladder Cancer Date Approved by Network Governance July 2012 Date for Review July 2015 Changes Between Version 3 and 4 Sections 5.2 and 8 updated Page 1 of 9 1. Scope of
More informationEnhanced Supportive Care. Dr Joanna Sheppard Dr Jane Neerkin
Enhanced Supportive Care Dr Joanna Sheppard Dr Jane Neerkin Supportive Care...more than palliative care Supportive care in cancer is the prevention and management of the adverse effects of cancer and its
More informationImaging techniques in the diagnosis, staging and follow up of GI cancers. Moderators: Banke Agarwal, MD and Paul Schultz, MD
Imaging techniques in the diagnosis, staging and follow up of GI cancers Moderators: Banke Agarwal, MD and Paul Schultz, MD Panelists Axel Grothey, MD Professor of Oncology Division of Medical Oncology
More informationGuideline for the Follow-up of Patients with Gynaecological Malignancies
Guideline for the Follow-up of Patients with Gynaecological Malignancies Version History Version Date Summary of Change/Process 2.0 20.02.08 Endorsed by the Governance Committee 2.1 18.11.10 Circulated
More informationSpecialist Referral Service Willows Information Sheets. Cancer in cats and dogs: Assessment of the patient
Specialist Referral Service Willows Information Sheets Cancer in cats and dogs: Assessment of the patient Cancer in cats and dogs: Assessment of the patient Cancer is common in human and veterinary medicine.
More informationDavid Brooks Macmillan Consultant in Palliative Medicine
Developing a new pathway for CUP patients at Chesterfield Royal Hospital David Brooks Macmillan Consultant in Palliative Medicine Philippa Hughes, Claire Farrington, Bill Noble, Peter Bath, Lingesan Gokulkrishnan,
More informationSouth West Cancer Alliances Rapid Diagnostic Pathway for Lung Cancer Project Evaluation
Somerset, Wiltshire, Avon and Gloucestershire Cancer Alliance Peninsula Cancer Alliance South West Cancer Alliances Rapid Diagnostic Pathway for Lung Cancer Project Evaluation Peninsula Thoracic-Oncology
More informationSupra Network Sarcoma Advisory Group (SAG) Annual Report
London and South East Sarcoma Network Supra Network Sarcoma Advisory Group (SAG) Annual Report 2011-2012 Hosted by Date: December 2012 Version: 2 Review Date: September 2013 London Cancer Integrated Cancer
More informationSOUTH EAST SCOTLAND CANCER NETWORK PROSPECTIVE CANCER AUDIT
SOUTH EAST SCOTLAND CANCER NETWORK PROSPECTIVE CANCER AUDIT BREAST CANCER 2013 COMPARATIVE AUDIT REPORT Mr Glyn Neades Chair Breast Group and Consultant Surgeon, NHS Fife Mr Matthew Barber, Consultant
More information